As of 2025-11-06, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is 0.55 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 5.80 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -90.5%.
The range of the Relative Valuation is 0.02 - 2.02 CAD.
| Range | Selected | |
| Trailing P/E multiples | 5.9x - 307.7x | 7.3x |
| Forward P/E multiples | 9.1x - 21.5x | 11.4x |
| Fair Price | 0.02 - 2.02 | 0.55 |
| Upside | -99.6% - -65.2% | -90.5% |
| Date | P/E |
| 2025-11-04 | 1,509.51 |
| 2025-11-03 | 1,519.92 |
| 2025-10-31 | 1,519.92 |
| 2025-10-30 | 1,509.51 |
| 2025-10-29 | 1,496.50 |
| 2025-10-28 | 1,517.32 |
| 2025-10-27 | 1,525.13 |
| 2025-10-24 | 1,517.32 |
| 2025-10-23 | 1,527.73 |
| 2025-10-22 | 1,509.51 |
| 2025-10-21 | 1,525.13 |
| 2025-10-20 | 1,530.34 |
| 2025-10-17 | 1,504.31 |
| 2025-10-16 | 1,504.31 |
| 2025-10-15 | 1,496.50 |
| 2025-10-14 | 1,496.50 |
| 2025-10-10 | 1,501.71 |
| 2025-10-09 | 1,532.94 |
| 2025-10-08 | 1,527.73 |
| 2025-10-07 | 1,522.53 |
| 2025-10-06 | 1,538.14 |
| 2025-10-03 | 1,522.53 |
| 2025-10-02 | 1,517.32 |
| 2025-10-01 | 1,543.35 |
| 2025-09-30 | 1,530.34 |
| 2025-09-29 | 1,540.75 |
| 2025-09-26 | 1,543.35 |
| 2025-09-25 | 1,582.39 |
| 2025-09-24 | 1,579.78 |
| 2025-09-23 | 1,571.98 |
| 2025-09-22 | 1,608.41 |
| 2025-09-19 | 1,621.43 |
| 2025-09-18 | 1,613.62 |
| 2025-09-17 | 1,621.43 |
| 2025-09-16 | 1,639.64 |
| 2025-09-15 | 1,652.66 |
| 2025-09-12 | 1,650.06 |
| 2025-09-11 | 1,673.48 |
| 2025-09-10 | 1,665.67 |
| 2025-09-09 | 1,673.48 |
| 2025-09-08 | 1,678.68 |
| 2025-09-05 | 1,676.08 |
| 2025-09-04 | 1,676.08 |
| 2025-09-03 | 1,683.89 |
| 2025-09-02 | 1,678.68 |
| 2025-08-29 | 1,691.70 |
| 2025-08-28 | 1,665.67 |
| 2025-08-27 | 1,689.09 |
| 2025-08-26 | 1,691.70 |
| 2025-08-25 | 1,702.11 |